Characteristic

Frequency, n(%)

Age

9 - <20

26 (12.7)

20 - <30

17 (8.3)

30 - <40

44 (21.5)

40 - <50

64 (31.2)

50 - <60

34 (16.6)

≥60

20 (9.8)

Gender

Male

91 (44.4)

Female

114 (55.6)

N(t)RTI

Zidovudine

116 (56.6)

Stavudine

69 (33.7)

Tenofovir

20 (9.8)